Sanbo Brain Hospital released its 2026 interim report. Total operating revenue was 971 million yuan, and net profit attributable to the parent company was 32.7491 million yuan, down 53.01% from the same period last year, a decrease of 36.9466 million yuan. Net cash inflow from operating activities was 117 million yuan. The company's latest asset-liability ratio was 32.19%, up 0.22 percentage points from the previous quarter and up 3.71 percentage points from the same period last year. Gross margin was 22.45%, down 3.68 percentage points from the same period last year. Return on equity was 1.38%, down 1.60 percentage points from the same period last year. Diluted earnings per share were 0.16 yuan, down 52.94% year-on-year. The company had 54,600 shareholders, and the top ten shareholders held 41.44% of the total share capital.
Sanbo Hospital Management Group Ltd. ANet profit down 53.01% year-on-year, with lower gross margin and ROE.
